TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.

Andy C Rawstron et al.PubMed ↗Publisher ↗

No numbers read from the abstract.